Overview:

A veterinary active pharmaceutical ingredient (API) is any chemical substance in a pharmaceutical drug that produces any desired effect in the animals. Veterinary APIs can be a combination of two or more substances in a drug intended to provide some pharmacological effect. Veterinary APIs market is formidable in size and expected to escalate during the forecast period. The prominent factors that catalyze the growth of the global veterinary APIs market include increasing infrastructure and growing healthcare facilities for animal healthcare in developed as well as in developing countries. Furthermore, strategic initiatives by vendors, rising pet adoption, flexible regulations, unmet medical needs, and outsourcing of the veterinary APIs manufacturing fuels the growth of the global market.

Among the API types, in 2017, antiparasitics segment dominated the global veterinary APIs market, in terms of market value, and expected to retain its dominance during the forecast period. The dominance of antiparasitics is attributed to a large number of pharmaceutical industries particularly focusing on the antiparasitic APIs, and high reporting of parasite infliction in companion animals and cattle alike.

Veterinary APIs manufacturing trend greatly differs from the veterinary APIs consumption. Asia Pacific dominates the global market in terms of manufacturing of the APIs. Conversely, consumption of veterinary APIs is dominated by North America owing to the presence of numerous pharmaceutical manufacturing companies in the region. Asia Pacific is identified to be the most lucrative market segment owing to the growing adoption of pets and their treatment facilities.

The veterinary APIs market is highly fragmented due to the presence of numerous players competing in the market. The competition greatly influences the market in terms of pricing of the APIs. Furthermore, there are instances of illegal selling of APIs directly to the pet owners to use as a drug which negatively impacts the value chain.

The Veterinary Active Pharmaceutical Ingredients (APIs) Market is segmented on the following bases:

• Global Veterinary Active Pharmaceutical Ingredients Market, by API Type, 2016-2026 (US$ Mn)
  • Antiparasitics
  • Anti-infectives
  • NSAIDs & Anesthetics
  • Others (Beta Agonists, Cardiovascular, Gastroenteric etc.)
• Global Veterinary Active Pharmaceutical Ingredients Market, by Geography, 2016-2026 (US$ Mn)
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Rest of APAC
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East and Africa (MEA)
    • GCC
    • Rest of MEA

Key Players Identified in Veterinary Active Pharmaceutical Ingredients Market include:

Ofichem BV, Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Changzhou Yabang Qh Pharmachem Co., Ltd., Eli Lilly & Co., Glenmark Pharmaceutical Limited., Indukern, S.A., P&R S.p.A (Olon S.p.A), Huvepharma AD, Ourofino Saude Animal, Blanver Farmoquimica E Farmaceutica S.A., Sequent Scientific Ltd., NGL Fine-Chem Ltd., Omkar Speciality Chemicals Ltd., and Excel Industries Ltd.

This report offers:

• A comprehensive market outlook and future dynamics of the global veterinary active pharmaceutical ingredients market
• Global veterinary active pharmaceutical ingredients market elucidation at granular level by segmentation of market based on various parameters.
• Market estimations of the global veterinary active pharmaceutical ingredients market for the span of 10 years from 2016 to 2026 and quantifies the growth of the market during the forecast period.
• Profiling of the key players operating in the veterinary active pharmaceutical ingredients market along with graphical positioning of the major players